WMA
IONS icon

West Michigan Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

West Michigan Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.35M Buy
44,614
+6,201
+16% +$489K 0.74% 40
2025
Q4 		$3.04M Buy
+38,413
New +$2.89M 0.7% 34

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

West Michigan Advisors's IONS Position: Q1 2026 in Review

West Michigan Advisors increased its Ionis Pharmaceuticals (IONS) stake by 16% in Q1 2026, buying an estimated $489K and bringing the position to 44,614 shares worth $3.35M. The position accounts for 0.74% of the portfolio, ranked #40.

West Michigan Advisors first reported a position in IONS in Q4 2025 and has held it in 2 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • West Michigan Advisors held 44,614 shares of Ionis Pharmaceuticals worth $3.35M as of Q1 2026.
  • West Michigan Advisors bought 6,201 Ionis Pharmaceuticals shares in Q1 2026, an estimated $489K.
  • Ionis Pharmaceuticals made up 0.74% of West Michigan Advisors's portfolio in Q1 2026, its #40 holding.
  • West Michigan Advisors first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on West Michigan Advisors's 13F filing for Q1 2026, filed 5 May 2026.